Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sotagliflozin Safety and Tolerability Among Renal Transplant Recipients

NCT05405556 is registered in ClinicalTrials.gov with Martina McGrath, MD as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05405556 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sotagliflozin Safety and Tolerability Among Renal Transplant Recipients
Lead sponsor
Martina McGrath, MD
Phase
Phase 2
Overall status
Completed
Start date
October 17, 2022
Completion date
November 16, 2024
Enrollment
40 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

kidney transplant